Literature DB >> 25227321

The value of anti-desmoglein enzyme-linked immunosorbent assay in the immunological follow-up of pemphigus.

Nathalia Bellon1, Chantal André, Emilie Sbidian, Nicolas Ortonne, Pierre Wolkenstein, Olivier Chosidow, Saskia Ingen-Housz-Oro.   

Abstract

BACKGROUND: The value of anti-desmoglein 1 and 3 (Dsg1, Dsg3) enzyme-linked immunosorbent assay (ELISA) is controversial in the follow-up of pemphigus.
OBJECTIVE: To evaluate anti-desmoglein ELISA (Dsg ELISA) in the follow-up of pemphigus and compare ELISA with direct and indirect immunofluorescence in complete remission (CR).
METHODS: We performed a retrospective monocenter study of patients with pemphigus and consecutive sera samples collected at baseline (M0), 12 months (M12) and 24 or 36 months after M0 (M24/36). Tests were compared in CR and in active disease. Direct immunofluorescence and circulating autoantibodies were compared for patients with stable CR.
RESULTS: We included 36 patients. At M12, ELISA values did not differ between CR and active disease. At M24/36, Dsg3 but not Dsg1 ELISA values were lower in CR (p = 0.07). For 5/8 patients with stable CR, direct immunofluorescence and ELISA findings remained positive.
CONCLUSION: In routine practice, Dsg ELISA seems to be of little interest for immunological follow-up of pemphigus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25227321     DOI: 10.1159/000365079

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

Review 1.  New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature.

Authors:  Rachel R Xuan; Anes Yang; Dedee F Murrell
Journal:  Int J Womens Dermatol       Date:  2018-02-03

2.  Autoantibodies against Desmoglein 1 and 3 in South Tunisian pemphigus.

Authors:  Ameni Jerbi; Hend Hachicha; Sawsan Feki; Olfa Abida; Emna Bahloul; Khadija Sellami; Amina Bouzid; Hamida Turki; Abderrahmen Masmoudi; Hatem Masmoudi
Journal:  Tunis Med       Date:  2021 Octobre
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.